Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Basic) (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of EPS (Basic) data on record, last reported at $0.98 in Q4 2025.

  • For Q4 2025, EPS (Basic) fell 20.33% year-over-year to $0.98; the TTM value through Dec 2025 reached $3.81, down 11.6%, while the annual FY2025 figure was $4.32, 2.61% up from the prior year.
  • EPS (Basic) reached $0.98 in Q4 2025 per PBH's latest filing, up from $0.86 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.23 in Q4 2024 and bottomed at -$4.82 in Q1 2023.
  • Average EPS (Basic) over 5 years is $0.72, with a median of $1.02 recorded in 2022.
  • Peak YoY movement for EPS (Basic): crashed 563.46% in 2023, then soared 120.75% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $1.0 in 2021, then grew by 5.0% to $1.05 in 2022, then increased by 1.9% to $1.07 in 2023, then rose by 14.95% to $1.23 in 2024, then dropped by 20.33% to $0.98 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $0.98 in Q4 2025, $0.86 in Q3 2025, and $0.96 in Q2 2025.